Showing 1 - 20 results of 7,306 for search '(( n marked decrease ) OR ((( c ((e decrease) OR (mean decrease)) ) OR ( a marker decrease ))))', query time: 0.61s Refine Results
  1. 1
  2. 2

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…<p>(A) Representative images showed calcium deposition (red). (B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
  3. 3
  4. 4
  5. 5

    Effects of GJE extract treatment decreased expression of NF-kB p65. by Natnicha Suttawong (22367172)

    Published 2025
    “…The percentage of positive staining for NF-kB p65 (E). Data are expressed as mean ± SD, error bars indicate standard deviation, n = 6/group. a: when compared to the control group. b: when compared to the NF group, <i><i>p</i></i> < 0.05 for both a and b.…”
  6. 6
  7. 7

    Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

    Published 2025
    “…<p>(a) Left: noise-evoked activity rates at different noise intensities for chronically tracked PPys cells in baseline and repeated stress conditions (<i>N</i> = 5 mice, <i>n</i> = 285 neurons, mean ± SE). …”
  8. 8

    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…Summarized bar graphs showed EVO significantly decreased mRNA expression of pyroptotic markers (B) NLRP3 and (C) GSDM-D in CER treated P<sub>i</sub>-induced VSMCs. …”
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20